IVD News and Research

RSS
Debiopharm, Spinomix announce closing of Series A equity financing

Debiopharm, Spinomix announce closing of Series A equity financing

Samsung Medison highlights medical devices at RNSA 2012 meeting

Samsung Medison highlights medical devices at RNSA 2012 meeting

New report analyzes annual trends for biomarker FDA approvals since 2008

New report analyzes annual trends for biomarker FDA approvals since 2008

HORIBA Europe opens new R&D facility

HORIBA Europe opens new R&D facility

Affymetrix reports net loss of $17.9 million for third quarter 2012

Affymetrix reports net loss of $17.9 million for third quarter 2012

Bruker introduces Toxtyper clinical mass spectrometry solution

Bruker introduces Toxtyper clinical mass spectrometry solution

Diabetes prevention: an interview with Julian Baines, CEO of EKF Diagnostics

Diabetes prevention: an interview with Julian Baines, CEO of EKF Diagnostics

PathGEN signs Powered by Affymetrix Program agreement

PathGEN signs Powered by Affymetrix Program agreement

Roche MagNA Pure 96 System's CE certified IVD version launched

Roche MagNA Pure 96 System's CE certified IVD version launched

Clovis Oncology, Foundation Medicine enter diagnostic collaboration

Clovis Oncology, Foundation Medicine enter diagnostic collaboration

Cepheid launches new Xpert BCR-ABL Monitor test

Cepheid launches new Xpert BCR-ABL Monitor test

ERBA Diagnostics to showcase full range of products at AACC annual meeting

ERBA Diagnostics to showcase full range of products at AACC annual meeting

SurModics IVD to introduce BioFX TMB Extended Range HRP Microwell Substrate

SurModics IVD to introduce BioFX TMB Extended Range HRP Microwell Substrate

Evolution of Advanced IVDs Conference to take place on September 19-20, 2012

Evolution of Advanced IVDs Conference to take place on September 19-20, 2012

SQI raises CDN $754,000 in third and final tranche of private placement

SQI raises CDN $754,000 in third and final tranche of private placement

Enzo Biochem third quarter total revenue increases 4% to $26 million

Enzo Biochem third quarter total revenue increases 4% to $26 million

End-to-end regulatory solution for medical device companies in Europe offered by new partnership between ELC and mdi Europa

End-to-end regulatory solution for medical device companies in Europe offered by new partnership between ELC and mdi Europa

Ventana, leading cancer researchers partner to commercialize novel IHC primary antibody

Ventana, leading cancer researchers partner to commercialize novel IHC primary antibody

SQI Diagnostics reports net loss of $1,350,000 for second quarter 2012

SQI Diagnostics reports net loss of $1,350,000 for second quarter 2012

Laboratory middleware solution to be exhibited by NoemaLife at this year’s AACC

Laboratory middleware solution to be exhibited by NoemaLife at this year’s AACC